Incidence of intracranial germ cell tumors by race in the United States, 1992-2010.

PubWeight™: 0.76‹?›

🔗 View Article (PMC 4206671)

Published in J Neurooncol on August 03, 2014

Authors

Jenny N Poynter1, Rachel Fonstad, Jakub Tolar, Logan G Spector, Julie A Ross

Author Affiliations

1: Division of Epidemiology and Clinical Research, Department of Pediatrics, University of Minnesota, 420 Delaware St SE MMC 715, Minneapolis, MN, 55455, USA, poynt006@umn.edu.

Articles cited by this

Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol (2008) 21.53

Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol (2007) 16.81

The relative survival rate: a statistical methodology. Natl Cancer Inst Monogr (1961) 10.35

Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol (2009) 9.25

International Classification of Childhood Cancer, third edition. Cancer (2005) 8.55

CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009. Neuro Oncol (2012) 8.16

N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain (2010) 6.84

Three or more routes for leukocyte migration into the central nervous system. Nat Rev Immunol (2003) 4.76

Carcinogenicity of shift-work, painting, and fire-fighting. Lancet Oncol (2007) 4.60

Completeness of hospital cancer case reporting from the SEER Program of the National Cancer Institute. Cancer (1995) 3.78

Testicular germ-cell tumours in a broader perspective. Nat Rev Cancer (2005) 3.75

Trends in childhood cancer incidence in the U.S. (1992-2004). Cancer (2008) 3.71

The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project. Clin Infect Dis (2012) 3.63

Melatonin in humans. N Engl J Med (1997) 3.60

CNS immune privilege: hiding in plain sight. Immunol Rev (2006) 3.13

Intracranial germ-cell tumors: natural history and pathogenesis. J Neurosurg (1985) 2.93

International trends in the incidence of testicular cancer, 1973-2002. Cancer Epidemiol Biomarkers Prev (2010) 2.07

Childhood and adolescent cancer survival in the US by race and ethnicity for the diagnostic period 1975-1999. Cancer (2008) 2.04

The testis in immune privilege. Immunol Rev (2006) 1.77

How representative are the surveillance, epidemiology, and end results (SEER) program cancer data of the United States? Cancer Causes Control (2004) 1.59

Autoimmune encephalitis in children. J Child Neurol (2012) 1.53

Primary pediatric brain tumors: statistics of Taipei VGH, Taiwan (1975-2004). Cancer (2005) 1.42

Anti-N-methyl-D-aspartate receptor encephalitis: a newly recognized inflammatory brain disease in children. Arthritis Rheum (2011) 1.32

Immunological, paracrine and endocrine aspects of testicular immune privilege. Mol Cell Endocrinol (2010) 1.31

Ovarian teratoma associated with anti-N-methyl D-aspartate receptor encephalitis: a report of 5 cases documenting prominent intratumoral lymphoid infiltrates. Int J Gynecol Pathol (2012) 1.25

Radiation therapy for intracranial germinoma: results of the German cooperative prospective trials MAKEI 83/86/89. J Clin Oncol (1999) 1.23

CNS germ cell tumor (CNSGCT) of childhood: presentation and delayed diagnosis. Neurology (2007) 1.22

Why human extragonadal germ cell tumours occur in the midline of the body: old concepts, new perspectives. Int J Androl (2007) 1.22

Malignant pineal germ-cell tumors: an analysis of cases from three tumor registries. Neuro Oncol (2008) 1.16

Trends in incidence and survival of pediatric and adolescent patients with germ cell tumors in the United States, 1975 to 2006. Cancer (2010) 1.14

Incidence patterns of central nervous system germ cell tumors: a SEER Study. J Pediatr Hematol Oncol (2009) 1.11

Comparative incidence patterns and trends of gonadal and extragonadal germ cell tumors in England, 1979 to 2003. Cancer (2012) 1.10

Clinical epidemiology for childhood primary central nervous system tumors. J Neurooncol (2008) 1.07

Population-based epidemiological study of primary intracranial tumors in childhood. Childs Nerv Syst (2010) 1.05

Epidemiology of gonadal germ cell cancer in males and females. APMIS (2003) 1.03

Melatonin and human reproduction: shedding light on the darkness hormone. Gynecol Endocrinol (2009) 0.97

Primary CNS germ cell tumors in Japan and the United States: an analysis of 4 tumor registries. Neuro Oncol (2012) 0.95

Primary intracranial germ cell tumours. Acta Neuropathol (1973) 0.94

Intracranial germ cell tumours. A review with special reference to endocrine manifestations. Acta Oncol (2012) 0.89

First-morning urinary melatonin and breast cancer risk in the Guernsey Study. Am J Epidemiol (2014) 0.88

Cancer occurrence in Southeast Asian children in California. J Pediatr Hematol Oncol (2004) 0.88

Consensus conference on cancer registration of brain and central nervous system tumors. Neuro Oncol (2005) 0.86

Anti-N-methyl-D-aspartate receptor encephalitis in a young woman with an ovarian tumour. Hong Kong Med J (2010) 0.84

Delayed diagnosis in children with intracranial germ cell tumors. J Pediatr (2013) 0.84

Melatonin and human puberty: current perspectives. J Pineal Res (1993) 0.82

Natural history of the female germ cell from its origin to full maturation through prenatal ovarian development. Eur J Obstet Gynecol Reprod Biol (1997) 0.81

Paediatric germ cell tumours of the central nervous system: Results and experience from a tertiary-referral paediatric institution in Australia. J Clin Neurosci (2013) 0.78

5-Methoxytryptophol and melatonin in children: differences due to age and sex. J Pineal Res (1996) 0.76

Serum immunoreactive melatonin in boys with delayed puberty. Clin Endocrinol (Oxf) (1982) 0.76

Not hysteria: ovarian teratoma-associated anti-N-methyl-D-aspartate receptor encephalitis. Scott Med J (2012) 0.76

Necrotic mature ovarian teratoma associated with anti-N-methyl-D-aspartate receptor encephalitis. Pathol Res Pract (2012) 0.76

Articles by these authors

Trends in childhood cancer incidence in the U.S. (1992-2004). Cancer (2008) 3.71

Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13. Blood (2010) 3.39

Childhood cancer following neonatal oxygen supplementation. J Pediatr (2005) 3.39

Bone marrow transplantation for recessive dystrophic epidermolysis bullosa. N Engl J Med (2010) 2.82

Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32. Nat Genet (2010) 2.37

Genome-wide association study identifies two susceptibility loci for osteosarcoma. Nat Genet (2013) 2.21

Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas. Oncogene (2002) 2.16

Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975-2005. Cancer (2009) 2.13

Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation. Blood (2006) 2.10

Childhood and adolescent cancer survival in the US by race and ethnicity for the diagnostic period 1975-1999. Cancer (2008) 2.04

Effect of stem cell source on outcomes after unrelated donor transplantation in severe aplastic anemia. Blood (2011) 2.03

Outcomes after allogeneic hematopoietic cell transplantation for childhood cerebral adrenoleukodystrophy: the largest single-institution cohort report. Blood (2011) 2.01

Outcomes of transplantation using various hematopoietic cell sources in children with Hurler syndrome after myeloablative conditioning. Blood (2013) 1.91

Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia. Nat Genet (2013) 1.85

Anthropometric characteristics and risk of multiple myeloma. Epidemiology (2005) 1.85

TALEN-based gene correction for epidermolysis bullosa. Mol Ther (2013) 1.84

The latent human herpesvirus-6A genome specifically integrates in telomeres of human chromosomes in vivo and in vitro. Proc Natl Acad Sci U S A (2010) 1.82

Trends in leukemia incidence and survival in the United States (1973-1998). Cancer (2003) 1.81

Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL. Blood (2010) 1.79

Height, body mass index, and ovarian cancer: a pooled analysis of 12 cohort studies. Cancer Epidemiol Biomarkers Prev (2008) 1.77

Program death-1 signaling and regulatory T cells collaborate to resist the function of adoptively transferred cytotoxic T lymphocytes in advanced acute myeloid leukemia. Blood (2010) 1.77

Ethnicity and survival in childhood acute myeloid leukemia: a report from the Children's Oncology Group. Blood (2006) 1.74

Germline mutations in BRCA2: shared genetic susceptibility to breast cancer, early onset leukemia, and Fanconi anemia. Blood (2004) 1.67

Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy. Blood (2006) 1.58

Parental age and risk of childhood cancer: a pooled analysis. Epidemiology (2009) 1.50

Secular trends in response rates for controls selected by random digit dialing in childhood cancer studies: a report from the Children's Oncology Group. Am J Epidemiol (2007) 1.49

Sleeping Beauty transposon-mediated engineering of human primary T cells for therapy of CD19+ lymphoid malignancies. Mol Ther (2008) 1.47

Fruit and vegetable consumption and its relation to markers of inflammation and oxidative stress in adolescents. J Am Diet Assoc (2009) 1.46

Stable gene transfer and expression in human primary T cells by the Sleeping Beauty transposon system. Blood (2005) 1.40

Maternal diet and infant leukemia: the DNA topoisomerase II inhibitor hypothesis: a report from the children's oncology group. Cancer Epidemiol Biomarkers Prev (2005) 1.39

Methodological issues in evaluating environmental risk factors: a response to Ivanovski et al. Med Hypotheses (2009) 1.38

Depletion of endogenous tumor-associated regulatory T cells improves the efficacy of adoptive cytotoxic T-cell immunotherapy in murine acute myeloid leukemia. Blood (2009) 1.35

Anthropometric variables, physical activity, and incidence of ovarian cancer: The Iowa Women's Health Study. Cancer (2004) 1.28

Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemia. Blood (2012) 1.26

Targeting natural killer cells to acute myeloid leukemia in vitro with a CD16 x 33 bispecific killer cell engager and ADAM17 inhibition. Clin Cancer Res (2013) 1.26

Dietary flavonoid intake and risk of cancer in postmenopausal women: the Iowa Women's Health Study. Int J Cancer (2008) 1.24

A picornaviral 2A-like sequence-based tricistronic vector allowing for high-level therapeutic gene expression coupled to a dual-reporter system. Mol Ther (2005) 1.23

Dyskeratosis congenita: the first NIH clinical research workshop. Pediatr Blood Cancer (2009) 1.22

Carotenoid intakes and risk of breast cancer defined by estrogen receptor and progesterone receptor status: a pooled analysis of 18 prospective cohort studies. Am J Clin Nutr (2012) 1.21

Current international perspectives on hematopoietic stem cell transplantation for inherited metabolic disorders. Pediatr Clin North Am (2010) 1.21

A pooled analysis of 12 cohort studies of dietary fat, cholesterol and egg intake and ovarian cancer. Cancer Causes Control (2006) 1.17

Hematopoietic cell therapy for metabolic disease. J Pediatr (2007) 1.17

Trends in incidence and survival of pediatric and adolescent patients with germ cell tumors in the United States, 1975 to 2006. Cancer (2010) 1.14

Transplant outcomes in leukodystrophies. Semin Hematol (2010) 1.14

Early diagnosis of cerebral X-linked adrenoleukodystrophy in boys with Addison's disease improves survival and neurological outcomes. Eur J Pediatr (2011) 1.13

Intakes of fruit, vegetables, and carotenoids and renal cell cancer risk: a pooled analysis of 13 prospective studies. Cancer Epidemiol Biomarkers Prev (2009) 1.12

Cardiac functional and histopathologic findings in humans and mice with mucopolysaccharidosis type I: implications for assessment of therapeutic interventions in hurler syndrome. Pediatr Res (2005) 1.12

Hematopoietic reconstitution by multipotent adult progenitor cells: precursors to long-term hematopoietic stem cells. J Exp Med (2007) 1.09

CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells against primary MDS and MDSC CD33+ targets. Blood (2014) 1.09

The Childhood Leukemia International Consortium. Cancer Epidemiol (2013) 1.09

Estrogen replacement therapy and ovarian cancer. Epidemiology (2004) 1.09

Genetic susceptibility variants for chronic lymphocytic leukemia. Cancer Epidemiol Biomarkers Prev (2010) 1.09

The association between atopy and childhood/adolescent leukemia: a meta-analysis. Am J Epidemiol (2010) 1.09

Minicircle DNA-based gene therapy coupled with immune modulation permits long-term expression of α-L-iduronidase in mice with mucopolysaccharidosis type I. Mol Ther (2010) 1.08

Epidemiology of leukemia in children with Down syndrome. Pediatr Blood Cancer (2005) 1.08

Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita. Biol Blood Marrow Transplant (2013) 1.07

Insights into the mechanism of FTY720 and compatibility with regulatory T cells for the inhibition of graft-versus-host disease (GVHD). Blood (2007) 1.07

Feasibility of neonatal dried blood spot retrieval amid evolving state policies (2009-2010): a Children's Oncology Group study. Paediatr Perinat Epidemiol (2011) 1.06

Common occurrence of monoclonal B-cell lymphocytosis among members of high-risk CLL families. Br J Haematol (2010) 1.05

Non-steroidal anti-inflammatory drug use and risk of adult leukemia. Cancer Epidemiol Biomarkers Prev (2003) 1.04

Antioxidant intake from fruits, vegetables and other sources and risk of non-Hodgkin's lymphoma: the Iowa Women's Health Study. Int J Cancer (2010) 1.03

Detection of cotinine in newborn dried blood spots. Cancer Epidemiol Biomarkers Prev (2007) 1.03

Bias in studies of parental self-reported occupational exposure and childhood cancer. Am J Epidemiol (2003) 1.03

Comparability and representativeness of control groups in a case-control study of infant leukemia: a report from the Children's Oncology Group. Am J Epidemiol (2009) 1.03

The epidemiology of childhood leukemia with a focus on birth weight and diet. Crit Rev Clin Lab Sci (2007) 1.02

Birth order and risk of childhood cancer: a pooled analysis from five US States. Int J Cancer (2010) 1.02

Parental and infant characteristics and childhood leukemia in Minnesota. BMC Pediatr (2008) 1.02

Cotinine and trans 3'-hydroxycotinine in dried blood spots as biomarkers of tobacco exposure and nicotine metabolism. J Expo Sci Environ Epidemiol (2013) 1.01

High birthweight and cancer: evidence and implications. Cancer Epidemiol Biomarkers Prev (2006) 1.01

Glutathione S-transferase genotypes, genetic susceptibility, and outcome of therapy in childhood acute lymphoblastic leukemia. Blood (2002) 1.00

Childhood cancer in relation to parental race and ethnicity: a 5-state pooled analysis. Cancer (2010) 0.99

Parental exposure to medications and hydrocarbons and ras mutations in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group. Cancer Epidemiol Biomarkers Prev (2004) 0.99

Multipotent adult progenitor cells can suppress graft-versus-host disease via prostaglandin E2 synthesis and only if localized to sites of allopriming. Blood (2009) 0.98

History of allergy and reduced incidence of colorectal cancer, Iowa Women's Health Study. Cancer Epidemiol Biomarkers Prev (2007) 0.98

Chitotriosidase as a biomarker of cerebral adrenoleukodystrophy. J Neuroinflammation (2011) 0.98

Child and maternal household chemical exposure and the risk of acute leukemia in children with Down's syndrome: a report from the Children's Oncology Group. Am J Epidemiol (2006) 0.98

Comparative evaluation of set-level techniques in predictive classification of gene expression samples. BMC Bioinformatics (2012) 0.98

Genetic variants modify susceptibility to leukemia in infants: a Children's Oncology Group report. Pediatr Blood Cancer (2012) 0.97

A novel method for KIR-ligand typing by pyrosequencing to predict NK cell alloreactivity. Clin Immunol (2007) 0.96

Exposure to medical test irradiation and acute leukemia among children with Down syndrome: a report from the Children's Oncology Group. Pediatrics (2006) 0.96

Birth characteristics and Wilms tumor in Minnesota. Int J Cancer (2008) 0.96

Stromal cell-derived factor-1 and hematopoietic cell homing in an adult zebrafish model of hematopoietic cell transplantation. Blood (2011) 0.94

Cytidine deaminase genotype and toxicity of cytosine arabinoside therapy in children with acute myeloid leukemia. Br J Haematol (2008) 0.94

Characterization of the elemental composition of newborn blood spots using sector-field inductively coupled plasma-mass spectrometry. J Expo Sci Environ Epidemiol (2010) 0.94

SEGS: search for enriched gene sets in microarray data. J Biomed Inform (2007) 0.94

Adeno-associated virus-mediated delivery of a mutant endostatin in combination with carboplatin treatment inhibits orthotopic growth of ovarian cancer and improves long-term survival. Cancer Res (2006) 0.94

Birth characteristics, maternal reproductive history, and the risk of infant leukemia: a report from the Children's Oncology Group. Cancer Epidemiol Biomarkers Prev (2007) 0.93

Childhood cancer research network: a North American Pediatric Cancer Registry. Cancer Epidemiol Biomarkers Prev (2006) 0.93

Hepatoblastoma and low birth weight. Pediatr Blood Cancer (2004) 0.93

Glutathione S-transferase A1 genetic variants reduce busulfan clearance in children undergoing hematopoietic cell transplantation. J Clin Pharmacol (2008) 0.92

Keratinocytes from induced pluripotent stem cells in junctional epidermolysis bullosa. J Invest Dermatol (2012) 0.92

Targeting of the CNS in MPS-IH using a nonviral transferrin-alpha-L-iduronidase fusion gene product. Mol Ther (2008) 0.91